News Releases

News and information from The Leukemia & Lymphoma Society

LLS Announces New Chief Operating Officer, Chief Marketing Officer and General Counsel

Rye Brook, NY, (March 2, 2020) – The Leukemia & Lymphoma Society (LLS) announced today three new appointments to its leadership team, Troy Dunmire, EVP, chief operating officer, Lynn Godfrey, EVP, chief marketing officer and Dale Nissenbaum, EVP, general counsel. “I’m pleased to announce significant new leadership appointments at The Leukemia & Lymphoma Society (LLS), leaders who join our strong exec...

Short-Term Health Plans Leave Patients Vulnerable to Major Medical Bills, According to New Research

View full news release here. Washington, D.C. (February 25, 2020) – The Leukemia & Lymphoma Society (LLS) released today new research which shows the significant financial costs facing consumers treated for five serious conditions while enrolled in short-term health plans: lymphoma, heart attack, lung cancer, diabetes and mental health hospitalizations. The study, conducted by actuarial fir...

24 Patient Groups Endorse Expedited Supreme Court Review of ACA Case

WASHINGTON, D.C. (January 3, 2020) — Twenty-four organizations representing millions of patients strongly support the petitions filed today by state attorneys general and by the U.S. House of Representatives that seek expedited U.S. Supreme Court review of last month’s Texas v. United States ruling. The coalition issued the following statement: “Our organizations, representing millions of individuals and ...

Burlington Stores Raises More Than $5.8 Million For LLS This Year

Rye Brook, NY, (January 7, 2020) – Burlington Stores and The Leukemia & Lymphoma Society (LLS) teamed up for the 18th consecutive year to raise critical funds for cancer research and patient support to help save lives and bring smiles to those impacted. From September 9 through December 2, customers at Burlington’s more than 700 locations nationwide were encouraged to donate $1 or more at checkout to support ...

28 Patient Groups Disappointed in 5th Circuit Court Ruling in Texas v. U.S.

Washington, D.C., (December 19, 2019) — Yesterday, the U.S. Court of Appeals for the Fifth Circuit issued their ruling in Texas v. United States, striking down the Affordable Care Act’s individual mandate and remanding back to the district court the decision as to whether key patient protections will remain in the future. In response, more than 25 patient groups issued the following statement: “It is importa...

LLS and ASH Team Up to Connect Cancer Patients to Clinical Trials

Collaboration will provide critical clinical trial navigation services and support to patients and families Rye Brook, NY, (December 6, 2019) -  The Leukemia & Lymphoma Society (LLS) and the American Society of Hematology (ASH) announced today a collaboration to expand access to LLS’s unique free service providing clinical trials navigation and support to blood cancer patients and their families. With o...

Walgreens, Susan G. Komen and LLS Collaborate to Support Research

Deerfield, Ill., Dallas and Rye Brook, N.Y., (Oct. 22, 2019) — Walgreens announced today a new collaboration with Susan G. Komen and The Leukemia & Lymphoma Society to enable research in tough-to-treat cancers and increase access to care with a pledge to contribute more than $25 million to the organizations, collectively, over the next five years. Through a combination of corporate donations and in-sto...

Nearly 60% of Blood Cancer Patients Covered By Medicare Delay or Forgo Treatment

View full multimedia release here.  Rye Brook, N.Y. (October 21, 2019) – Survival of older patients with blood cancers continues to improve as more effective, less toxic therapies are introduced. However, these lifesaving treatments often are expensive and many cancer patients face financial burdens caused by ever-increasing healthcare costs. In fact, according to a new study  released toda...

Pages

Media Requests

Please send all media-related inquiries and interview requests to mediarelations@lls.org.
An LLS representative will respond as soon as possible.